ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 230 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $458,000 | -23.3% | 35,890 | -23.8% | 0.18% | -7.2% |
| Q1 2017 | $597,000 | +15.0% | 47,092 | +19.5% | 0.19% | +56.5% |
| Q3 2016 | $519,000 | -56.3% | 39,400 | -57.9% | 0.12% | -43.1% |
| Q2 2016 | $1,188,000 | -56.8% | 93,514 | -55.1% | 0.22% | -44.9% |
| Q1 2016 | $2,749,000 | -17.3% | 208,071 | -3.7% | 0.40% | +10.6% |
| Q4 2015 | $3,323,000 | -12.9% | 216,092 | -29.8% | 0.36% | -2.7% |
| Q3 2015 | $3,815,000 | -12.2% | 307,671 | -3.1% | 0.37% | -13.2% |
| Q2 2015 | $4,343,000 | -14.5% | 317,501 | -25.2% | 0.42% | -14.9% |
| Q1 2015 | $5,079,000 | +3016.0% | 424,688 | +3225.1% | 0.50% | +3012.5% |
| Q4 2014 | $163,000 | -87.0% | 12,772 | -86.3% | 0.02% | -85.2% |
| Q3 2014 | $1,250,000 | +2.0% | 93,171 | +22.0% | 0.11% | +12.5% |
| Q2 2014 | $1,226,000 | -47.6% | 76,388 | -57.8% | 0.10% | -2.0% |
| Q2 2013 | $2,341,000 | – | 180,885 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |